Clinical Trial Update: Dydrogesterone Versus Intravaginal Progesterone in the Luteal Phase Support [NA]

View source ↗

Summary

This is a completed clinical trial comparing dydrogesterone versus intravaginal progesterone for luteal phase support. The study targets luteal phase defect.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Luteal Phase Defect

Drugs mentioned

• Dydrogesterone (dydrogesterone)
• Progesterone, intravaginal (progesterone)

Snippet

Sponsor: University of Zagreb | Conditions: Luteal Phase Defect | NA | Status: COMPLETED